---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-009061"
form_type: "8-K/A"
ticker: "AEMD"
cik: "0000882291"
company_name: "AETHLON MEDICAL INC"
filed_at: "2023-12-22T23:59:59+00:00"
generated_at: "2026-06-07T08:37:38.584468+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aethlon Medical sets compensation for Frakes as Interim CEO ($500K salary) and Cipriani as COO ($390K)

## Summary
- James Frakes appointed Interim CEO effective Nov 7, 2023; base salary raised from $360K to $500K while in role.
- Guy Cipriani appointed SVP & COO effective Nov 7, 2023; base salary set at $390K; resigned from Board.
- Frakes also remains CFO and joined Board; salary may revert upon hiring of permanent CEO.
- Cipriani resigns from Board per terms; reports to Interim CEO then to new CEO when appointed.

## SEC filing metadata
- accession: 0001683168-23-009061
- form_type: 8-K/A
- ticker: AEMD
- cik: 0000882291
- company_name: AETHLON MEDICAL INC
- filed_at: 2023-12-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/aethlon_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-009061
- JSON: https://secwatch.observer/filing/0001683168-23-009061.json
- Plain text: https://secwatch.observer/filing/0001683168-23-009061.txt

## Key facts
- Executive change
  Guy F. Cipriani was appointed as Senior Vice President and Chief Operating Officer at AETHLON MEDICAL INC.
  - Action: appointed
  - Role: Senior Vice President and Chief Operating Officer
  source text: Effective as of the Effective Date, Guy F. Cipriani, formerly Senior Vice President and Chief Business Officer of the Company, (i) was appointed as the Company’s Senior Vice President and Chief Operating Officer and (ii) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm
- Executive change
  Charles J. Fisher, Jr., M.D. departed as Chief Executive Officer at AETHLON MEDICAL INC.
  - Action: departed
  - Role: Chief Executive Officer
  source text: (b) Departure of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm
- Executive change
  Guy F. Cipriani resigned as Director at AETHLON MEDICAL INC.
  - Action: resigned
  - Role: Director
  source text: Resignation of Guy F. Cipriani as Director
  evidence_url: https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm
- Executive change
  James B. Frakes was appointed as Interim Chief Executive Officer at AETHLON MEDICAL INC.
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: Effective as of the Effective Date, Mr. Frakes, Chief Financial Officer of the Company, was appointed as (i) Interim Chief Executive Officer of the Company, replacing Dr. Fisher, and (ii) a member of the Board of Directors of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm
- Executive change
  James B. Frakes was appointed as Member of the Board of Directors at AETHLON MEDICAL INC.
  - Action: appointed
  - Role: Member of the Board of Directors
  source text: Effective as of the Effective Date, Mr. Frakes, Chief Financial Officer of the Company, was appointed as (i) Interim Chief Executive Officer of the Company, replacing Dr. Fisher, and (ii) a member of the Board of Directors of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.